David D. W. Lee: Proud to be a part of the Pan-Asian adapted ESMO Clinical Practice Guideline
David D. W. Lee, Consultant Clinical Oncologist at the University of Malaya Medical Centre and a lecturer at the Faculty of Medicine, shared an article by S.-H. Lee on LinkedIn:
“Proud to be a part of the Pan-Asian adapted ESMO – Eur. Oncology Clinical Practice Guideline for oncogene-addicted metastatic NSCLC.
Incorporating the latest advancement and local differences in Asia.”
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with oncogene-addicted metastatic non-small-cell lung cancer.
Authors: S.-H. Lee, et al.
Dr. David Lee Dai Wee is a Consultant Clinical Oncologist at the University of Malaya Medical Centre and a lecturer at the Faculty of Medicine, University of Malaya. He is the principal investigator for multiple international multicenter clinical trials, specializing in early-phase studies, thoracic cancers, and head and neck cancers. Dr. Lee received the ASCO Leadership Development Program – Asia Pacific award in 2021-2022 and the ASCO International Development and Education Award (IDEA) in 2024, as well as the IASLC Academy Award in 2024.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023